167
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Prevalence and Associated Factors of Kidney Dysfunction in Patients with Hypertension and/or Diabetes Mellitus from a Primary Care Population in Northwest China

ORCID Icon, , , ORCID Icon, , , , , , , & ORCID Icon show all
Pages 7567-7578 | Published online: 02 Nov 2021

References

  • Herzog CA, Asinger RW, Berger AK, et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011;80(6):572–586. doi:10.1038/ki.2011.223
  • Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–272. doi:10.1016/S0140-6736(13)60687-X
  • Mills KT, Xu Y, Zhang W, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950–957. doi:10.1038/ki.2015.230
  • Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease - A systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi:10.1371/journal.pone.0158765
  • Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822. doi:10.1016/S0140-6736(12)60033-6
  • Wei H, Yan Y, Gong J, Dong J. Prevalence of kidney damage in Chinese elderly: a large-scale population-based study. BMC Nephrol. 2019;20(1):341. doi:10.1186/s12882-019-1525-5
  • Huang YM, Xu D, Long J, et al. Spectrum of chronic kidney disease in China: a national study based on hospitalized patients from 2010 to 2015. Nephrology. 2019;24(7):725–736. doi:10.1111/nep.13489
  • Laliberté F, Bookhart BK, Vekeman F, et al. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. J Manag Care Pharm. 2009;15(4):312–322. doi:10.18553/jmcp.2009.15.4.312
  • Ohta M, Babazono T, Uchigata Y, Iwamoto Y. Comparison of the prevalence of chronic kidney disease in Japanese patients with Type 1 and Type 2 diabetes. Diabet Med. 2010;27(9):1017–1023. doi:10.1111/j.1464-5491.2010.03049.x
  • Altun B, Süleymanlar G, Utaş C, et al. Prevalence, awareness, treatment and control of hypertension in adults with chronic kidney disease in Turkey: results from the CREDIT study. Kidney Blood Press Res. 2012;36(1):36–46. doi:10.1159/000339025
  • Cao Y, Li W, Yang G, Liu Y, Li X. Diabetes and hypertension have become leading causes of CKD in Chinese elderly patients: a comparison between 1990–1991 and 2009–2010. Int Urol Nephrol. 2012;44(4):1269–1276. doi:10.1007/s11255-012-0194-0
  • Zhang L, Wang H. Chronic kidney disease epidemic: cost and health care implications in China. Semin Nephrol. 2009;29(5):483–486. doi:10.1016/j.semnephrol.2009.06.012
  • Zhou M, Astell-Burt T, Bi Y, et al. Geographical variation in diabetes prevalence and detection in China: multilevel spatial analysis of 98,058 adults. Diabetes Care. 2015;38(1):72–81. doi:10.2337/dc14-1100
  • Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulation. 2018;137(22):2344–2356. doi:10.1161/CIRCULATIONAHA.117.032380
  • Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–2944. doi:10.1681/ASN.2006040368
  • Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3–15.
  • World Health Organization. Global Recommendations on Physical Activity for Health. Geneva: World Health Organization Copyright © World Health Organization 2010; 2010.
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. doi:10.1016/0165-1781(89)90047-4
  • Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008;51(3):373–384. doi:10.1053/j.ajkd.2007.11.009
  • Chen W, Liu Q, Wang H, et al. Prevalence and risk factors of chronic kidney disease: a population study in the Tibetan population. Nephrol Dial Transplant. 2011;26(5):1592–1599. doi:10.1093/ndt/gfq608
  • Varma PP, Raman DK, Ramakrishnan TS, Singh P, Varma A. Prevalence of early stages of chronic kidney disease in apparently healthy central government employees in India. Nephrol Dial Transplant. 2010;25(9):3011–3017. doi:10.1093/ndt/gfq131
  • Alam A, Amanullah F, Baig-Ansari N, Lotia-Farrukh I, Khan FS. Prevalence and risk factors of kidney disease in urban Karachi: baseline findings from a community cohort study. BMC Res Notes. 2014;7(1):179. doi:10.1186/1756-0500-7-179
  • Gasparini A, Evans M, Coresh J, et al. Prevalence and recognition of chronic kidney disease in Stockholm healthcare. Nephrol Dial Transplant. 2016;31(12):2086–2094. doi:10.1093/ndt/gfw354
  • Wang F, He K, Wang J, et al. Prevalence and risk factors for CKD: a comparison between the adult populations in China and the United States. Kidney Int Rep. 2018;3(5):1135–1143. doi:10.1016/j.ekir.2018.05.011
  • Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract. 2011;118(3):c269–c277. doi:10.1159/000321382
  • Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis. 2010;55(3):463–473. doi:10.1053/j.ajkd.2009.11.017
  • Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33(4):278–285. doi:10.1111/j.1532-5415.1985.tb07117.x
  • Silbiger SR, Neugarten J. The role of gender in the progression of renal disease. Adv Ren Replace Ther. 2003;10(1):3–14. doi:10.1053/jarr.2003.50001
  • Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73(1):19–33. doi:10.1038/sj.ki.5002586
  • Chan TC, Zhang Z, Lin BC, et al. Long-term exposure to ambient fine particulate matter and chronic kidney disease: a cohort study. Environ Health Perspect. 2018;126(10):107002. doi:10.1289/EHP3304
  • Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z. Particulate matter air pollution and the risk of incident CKD and progression to ESRD. J Am Soc Nephrol. 2018;29(1):218–230. doi:10.1681/ASN.2017030253
  • Chen SY, Chu DC, Lee JH, Yang YR, Chan CC. Traffic-related air pollution associated with chronic kidney disease among elderly residents in Taipei City. Environ Pollut. 2018;234:838–845. doi:10.1016/j.envpol.2017.11.084
  • Park S, Lee S, Kim Y, et al. Causal effects of physical activity or sedentary behaviors on kidney function: an integrated population-scale observational analysis and Mendelian randomization study. Nephrol Dial Transplant. 2021. doi:10.1093/ndt/gfab153
  • Parvathaneni K, Surapaneni A, Ballew SH, et al. Association between midlife physical activity and incident kidney disease: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2021;77(1):74–81. doi:10.1053/j.ajkd.2020.07.020
  • Tannor EK, Sarfo FS, Mobula LM, Sarfo-Kantanka O, Adu-Gyamfi R, Plange-Rhule J. Prevalence and predictors of chronic kidney disease among Ghanaian patients with hypertension and diabetes mellitus: a multicenter cross-sectional study. J Clin Hypertens. 2019;21(10):1542–1550. doi:10.1111/jch.13672
  • Mutie PM, Pomares-Millan H, Atabaki-Pasdar N, et al. An investigation of causal relationships between prediabetes and vascular complications. Nat Commun. 2020;11(1):4592. doi:10.1038/s41467-020-18386-9
  • James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010;375(9722):1296–1309. doi:10.1016/S0140-6736(09)62004-3
  • Ji A, Pan C, Wang H, et al. Prevalence and associated risk factors of chronic kidney disease in an elderly population from Eastern China. Int J Environ Res Public Health. 2019;16(22):22. doi:10.3390/ijerph16224383
  • Atkinson MA, Warady BA. Anemia in chronic kidney disease. Pediatr Nephrol. 2018;33(2):227–238. doi:10.1007/s00467-017-3663-y
  • Moazzeni SS, Arani RH, Hasheminia M, Tohidi M, Azizi F, Hadaegh F. High incidence of chronic kidney disease among Iranian diabetic adults: using CKD-EPI and MDRD equations for estimated Glomerular Filtration Rate. Diabetes Metab J. 2021;45(5):684–697. doi:10.4093/dmj.2020.0109
  • Kaze FF, Maimouna M, Beybey AF, et al. Prevalence and determinants of chronic kidney disease in urban adults’ populations of northern Cameroon. Clin Exp Nephrol. 2021;25(7):718–726. doi:10.1007/s10157-021-02036-5